Literature DB >> 16337851

Deletion mapping of 18q in conventional renal cell carcinoma.

Hiroshi Hirata1, Hideyasu Matsuyama, Hiroaki Matsumoto, Yoshihito Korenaga, Chietaka Ohmi, Shigeru Sakano, Satoru Yoshihiro, Katsusuke Naito.   

Abstract

Loss of heterozygosity (LOH) is frequently associated with the inactivation of tumor suppressor genes. 18q LOH has been frequently reported in colorectal cancer and lung cancer; however, allelic loss on 18q has not been investigated in renal cell carcinoma (RCC). We evaluated LOH on 18q using nine microsatellite markers in 126 with conventional RCC (cRCC). LOH was observed in more than one 18q microsatellite locus in 24 cRCC (19%). We found the highest frequency of LOH (13.5%) at 18q21.3, where the DCC gene is located. We also assessed the relationship between LOH frequency and patient clinical parameters. Patients with a family history of cancer had a significantly higher frequency of 18q LOH than those without such a history (P=0.0017). No associations were found with other parameters, including gender, tumor grade, tumor stage, smoking status, and body mass index. The results suggest that inactivation of tumor suppressor genes at 18q21.3, including DCC and SMAD4 as candidates, may be involved in the tumorigenesis of some conventional RCCs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16337851     DOI: 10.1016/j.cancergencyto.2005.03.010

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  6 in total

1.  Clinical relevance of miR-mediated HLA-G regulation and the associated immune cell infiltration in renal cell carcinoma.

Authors:  Simon Jasinski-Bergner; Christine Stoehr; Juergen Bukur; Chiara Massa; Juliane Braun; Stefan Hüttelmaier; Verena Spath; Roland Wartenberg; Wolfgang Legal; Helge Taubert; Sven Wach; Bernd Wullich; Arndt Hartmann; Barbara Seliger
Journal:  Oncoimmunology       Date:  2015-03-02       Impact factor: 8.110

2.  SMAD4 immunohistochemistry reflects genetic status in juvenile polyposis syndrome.

Authors:  Danielle Langeveld; W Arnout van Hattem; Wendy W J de Leng; Folkert H Morsink; Fiebo J W Ten Kate; Francis M Giardiello; G Johan A Offerhaus; Lodewijk A A Brosens
Journal:  Clin Cancer Res       Date:  2010-08-03       Impact factor: 12.531

3.  Chromosomal imbalances revealed in primary renal cell carcinomas by comparative genomic hybridization.

Authors:  Xue-Ling Kang; Hong Zou; Li Juan Pang; Wen Hao Hu; Jin Zhao; Yan Qi; Chun-Xia Liu; Jian Ming Hu; Jing-Xia Tang; Hong An Li; Wei Hua Liang; Xiang-Lin Yuan; Feng Li
Journal:  Int J Clin Exp Pathol       Date:  2015-04-01

4.  Association between copy-number alteration of +20q, -14q and -18p and cross-sensitivity to tyrosine kinase inhibitors in clear-cell renal cell carcinoma.

Authors:  Liang Wang; Yuqing Li; Yinfeng Lyu; Hui Wen; Chenchen Feng
Journal:  Cancer Cell Int       Date:  2020-10-06       Impact factor: 5.722

Review 5.  Cancer and forensic microsatellites.

Authors:  Karen Page; Eleanor A M Graham
Journal:  Forensic Sci Med Pathol       Date:  2008-02-02       Impact factor: 2.007

6.  Genistein downregulates onco-miR-1260b and inhibits Wnt-signalling in renal cancer cells.

Authors:  H Hirata; K Ueno; K Nakajima; Z L Tabatabai; Y Hinoda; N Ishii; R Dahiya
Journal:  Br J Cancer       Date:  2013-04-16       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.